UnitedHealth Group Incorporated
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-96.4% vs price
Base Case (Median)
-66.7% vs price
Bull Case (75th pct.)
-47.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $203.80 | -98.9% | High (40%) |
| PE Comparable | $300.75 | -98.4% | Medium (25%) |
| Growth Trajectory DCF | $12300.10 | -33.2% | Medium (20%) |
| Graham Number | $1022.35 | -94.4% | Medium (40%) |
| EV/EBITDA | $7191.66 | -60.9% | Medium (20%) |
| EV/FCF | $14868.80 | -19.2% | Medium (20%) |
| Earnings Power Value | $6127.66 | -66.7% | Medium (50%) |
Based on 7 out of 8 methods, UNH.BA appears overvalued at the current price of $18400.00. The base case fair value of $6127.66 implies 66.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.